Pape et al. link the CD5-CK2-STAT3 signalling pathway to both inflammation and effector function in multiple sclerosis, using a multi-modal approach that combines functional assays, targeted single-cell RNA sequencing of CSF, and proteomic analyses of CSF and serum. Here, CD5 is linked to multiple sclerosis.